Record Q1 2026: Eight MedTech Innovators Choose Enlil

Eight MedTech innovators chose Enlil in Q1 2026. Most replaced their legacy QMS and PLM systems.

What a quarter! 🚀

Today we’re sharing the news officially: Enlil capped a record Q1 2026 by welcoming eight new MedTech customers across organ perfusion, surgical innovation, AI-driven imaging, kidney care, women’s health, and more. Most came to us from legacy systems, including Greenlight Guru and PTC Arena, and chose to standardize on Enlil’s AI-powered development traceability platform.

A few highlights:

✅ 8 new MedTech customers signed in 90 days

✅ Featured customers: Vascular Perfusion Solutions, iSono Health, and Verionyx (formerly FBR Medical)

✅ A first look at what’s next — Ask Lily, Milestone View, Change Impact, and the AI-first foundation powering Enlil’s platform

To our Q1 customers: thank you for trusting us with mission-critical work.

To the entire Enlil team: thank you for setting, and resetting, the bar on what modern, fast implementations look like in regulated MedTech.

Read the full announcement on PR Newswire:
#MedTech #MedicalDevices #QualityManagement #PLM #AI #RegulatoryCompliance